학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 307건 | 목록 1~10
Academic Journal
Iqbal M; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida. Electronic address: Iqbal.madiha@mayo.edu.; Kumar A; Department of Internal Medicine, Research Methodology and Biostatistics Core, Office of Research, University of South Florida Morsani College of Medicine, Tampa, Florida.; Dreger P; Department of Medicine V, University of Heidelberg, Heidelberg, Germany.; Chavez J; Moffitt Cancer Center, Tampa, Florida.; Sauter CS; Division of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio.; Sureda AM; Department of Hematology, Institut Català d'Oncologia (ICO), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Bachanova V; University of Minnesota, Minneapolis, Minnesota.; Maziarz RT; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Dreyling M; Department of Internal Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.; Smith SM; Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois.; Jacobson C; Dana-Farber Cancer Institute, Boston, Massachusetts.; Glass B; Klinik für Hämatologie und Stammzelltransplantation, HELIOS Klinikum Berlin-Buch, Berlin, Germany.; Casulo C; Department of Hematology/Oncology, University of Rochester, Rochester, New York.; Oluwole OO; Vanderbilt University Medical Center, Nashville Tennessee.; Montoto S; Department of Haemato-oncology St.Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Advani R; Department of Medicine, Stanford University, Stanford, California.; Cohen J; Emory University, Atlanta, Georgia.; Salles G; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Hamad N; Department of Haematology, St Vincent's Hospital Sydney, Australia. School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Australia. School of Medicine, Sydney, University of Notre Dame Australia, Sydney, New South Wales, Australia.; Kuruvilla J; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Kahl BS; Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri.; Shadman M; Fred Hutchinson Cancer Center, Seattle, Washington.; Kanate AS; HonorHealth Cancer Transplant Institute, Scottsdale, Arizona.; Budde LE; City of Hope National Medical Center, Duarte, California.; Kamdar M; University of Colorado Cancer Center, Aurora, Colorado.; Flowers C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hamadani M; CIBMTR/Medical College of Wisconsin, Milwaukee, Wisconsin.; Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Academic Journal
Ahmed N; University of Kansas Cancer Center, Westwood, Kansas, United States.; Wesson W; University of Kansas Cancer Center, Westwood, Kansas, United States.; Lutfi F; University of Kansas Medical Center, Westwood, Kansas, United States.; Porter DL; University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States.; Bachanova V; University of Minnesota, Minneapolis, Minnesota, United States.; Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Perales MA; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Maziarz RT; Knight Cancer Institute, Portland, Oregon, United States.; Brower J; University of Pennsylvania, Philadelphia, Pennsylvania, United States.; Shah GL; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Chen AI; Knight Cancer Institute, Oregon Health & Science University.; Oluwole OO; Vanderbilt University Medical Center, Nashville, Tennessee, United States.; Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States.; Bishop MR; University of Chicago, Chicago, Illinois, United States.; McGuirk JP; University of Kansas Cancer Center, Westwood, Kansas, United States.; Riedell PA; The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, Illinois, United States.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Vadgama S; Kite, A Gilead company, Uxbridge, United Kingdom.; Pasquini MC; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin Cancer Center, Milwaukee, WI.; Maziarz RT; Knight Cancer Institute, Portland, OR.; Hu ZH; Kite, A Gilead company, Santa Monica, CA.; Ray M; Kite, A Gilead company, Santa Monica, CA.; Smith H; Kite, A Gilead company, Uxbridge, United Kingdom.; Bullement A; Delta Hat Limited, Nottingham, United Kingdom.; Edmondson-Jones M; Delta Hat Limited, Nottingham, United Kingdom.; Sullivan W; Delta Hat Limited, Nottingham, United Kingdom.; Cartron G; Department of Hematology, CHU Montpellier, Montpellier, France.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Maziarz RT; Center for Hematologic Malignancies, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Cook RJ; Center for Hematologic Malignancies, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE
Academic Journal
Niehus HD; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA, niehus@ohsu.edu.; Sabile J; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Maziarz RT; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Meyers G; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Cook R; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Gandhi AP; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Saultz JN; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Rakshe S; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Kaempf A; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Braun T; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Migdady Y; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662 (Electronic) Linking ISSN: 00015792 NLM ISO Abbreviation: Acta Haematol Subsets: MEDLINE
Academic Journal
Ghilardi G; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Williamson S; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.; Pajarillo R; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Paruzzo L; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Chen L; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Grady C; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.; Doucette A; Division of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia.; Nemecek E; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.; Gabrielli G; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Barta SK; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Svoboda J; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Chong EA; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Yelton R; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Nasta SD; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Landsburg DJ; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Ugwuanyi O; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Chen AI; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.; Schachter L; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.; White G; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Ballard HJ; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Weber E; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Curley C; Division of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia.; Porter DL; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Garfall AL; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Hwang WT; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.; Guerra CE; Division of General Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Maziarz RT; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.; Schuster SJ; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Ruella M; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.
Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE
Academic Journal
Saber W; Medical College of Wisconsin, Milwaukee, WI.; Bansal A; Fred Hutchinson Cancer Center, Seattle, WA.; University of Washington, Seattle, WA.; Li L; Fred Hutchinson Cancer Center, Seattle, WA.; Scott BL; Fred Hutchinson Cancer Center, Seattle, WA.; Sangaralingham LR; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.; Department of Health Sciences Research, Division of Health Care Policy and Research (X.Y., N.D.S.), Mayo Clinic, Rochester, MN.; Thao V; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.; Department of Health Sciences Research, Division of Health Care Policy and Research (X.Y., N.D.S.), Mayo Clinic, Rochester, MN.; Roth JA; University of Washington, Seattle, WA.; Pfizer Inc, New York, NY.; Wright W; Fred Hutchinson Cancer Center, Seattle, WA.; Steuten LMG; Office of Health Economics, London, United Kingdom.; Pidala JA; Moffitt Cancer Center, Tampa, FL.; Mishra A; Moffitt Cancer Center, Tampa, FL.; Maziarz RT; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Westervelt P; Washington University, St Louis, MO.; McGuirk JP; University of Kansas Medical Center, Kansas City, KS.; Cutler C; Dana Farber Cancer Institute, Boston, MA.; Nakamura R; City of Hope National Medical Center, Duarte, CA.; Ramsey SD; Fred Hutchinson Cancer Center, Seattle, WA.; University of Washington, Seattle, WA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE
Academic Journal
Maziarz RT; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.; Gergis U; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA.; Edwards ML; Analysis Group, New York, NY.; Song Y; Analysis Group, Boston, MA.; Liu Q; Analysis Group, Boston, MA.; Anderson A; Analysis Group, New York, NY.; Signorovitch J; Analysis Group, Boston, MA.; Manghani R; Gamida Cell Ltd, Boston, MA.; Simantov R; Gamida Cell Ltd, Boston, MA.; Shin H; Gamida Cell Ltd, Boston, MA.; Sivaraman S; Gamida Cell Ltd, Boston, MA.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
De Sa H; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Maziarz RT; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Gandhi AP; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE
Academic Journal
Bubalo JS; Oregon Health & Science University, Portland, OR, USA.; Radke JL; Oregon Health & Science University, Portland, OR, USA.; Bensch KG; Oregon Health & Science University, Portland, OR, USA.; VA Portland Health Care System, Portland, OR, USA.; Chen AI; Oregon Health & Science University, Portland, OR, USA.; Misra S; Oregon Health & Science University, Portland, OR, USA.; Maziarz RT; Oregon Health & Science University, Portland, OR, USA.; Center for Hematologic Malignancies, OHSU Knight Cancer Institute, Beaverton, OR, USA.
Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Maziarz RT
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어